Drug Trial Radar · NCT00843921
N-Carbamylglutamate (Carbaglu) In The Treatment Of Hyperammonemia
Last checked: Nov 20, 2026Latest source record: Feb 17, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
52
Actual
Start
Aug 2008
Primary completion
Apr 25, 2018
Study completion Jun 30, 2020
Sponsor
- Lead sponsor
- Mendel TuchmanAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- First posted
- Feb 13, 2009
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 1 day, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is based on the hypothesis that a new drug N-carbamylglutamate (Carbaglu®) will enhance the ability of the liver to dispose of toxic ammonia which accumulates in several metabolic diseases including urea cycle disorders and organic acid disorders.
Conditions
- Inborn Errors of Metabolism
Interventions
N-carbamylglutamateDrug
100 mg/kg/day or 2.2 g/M2/day in 3-4 divided doses for 3 days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Rate of ureagenesis as determined by 13C enrichment of ureaTime frame: 3 days of treatment
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Childrens Research Institute
Washington D.C., District of Columbia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.